Cardinal Health shares rise after profit forecast beats estimates
Shares of drug distributor Cardinal Health CAH.N rise ~7% to a record high of $256.25
Co sees annual adjusted profit of $12.40-$12.60/shr vs analysts' average estimate of $12.04/shr — LSEG data
Co reports Q4 adj. profit of $2.91/shr vs analysts' average estimate of $2.42/shr — LSEG data
Co's quarterly revenue of $63.70 billion misses analysts' average expectation of $65.03 billion
Leerink Partners analyst Michael Cherny says Cardinal's FY2027 profit forecast came in "comfortably" above consensus and shows a path for "ongoing momentum"; maintains "Outperform" rating on the stock
CAH•
